| Literature DB >> 10681698 |
M Hayashi1, M Izawa, H Hiyama, S Nakamura, S Atsuchi, H Sato, K Nakaya, K Sasaki, T Ochiai, O Kubo, T Hori, K Takakura.
Abstract
Ninety-two patients with pituitary adenomas have been treated during the last 5 years. Sixty-three of these patients had more than 6 months follow-up, and they form the basis of this report. Eighteen had non-functioning adenomas (NFA), and 36 had functioning adenomas (FA). The mean marginal dose was 22.5 Gy (NFA 19.5 Gy, FA 23.9 Gy). Control of tumor growth was achieved in 92%. A significant decrease of excessive hormone production was seen in 75.6%, and the endocrinopathy normalization rate was 26.7%. Post-radiosurgical complications were seen in 4.7%.Entities:
Mesh:
Year: 1999 PMID: 10681698 DOI: 10.1159/000056446
Source DB: PubMed Journal: Stereotact Funct Neurosurg ISSN: 1011-6125 Impact factor: 1.875